‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometry
- 1 April 2006
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 29 (2-3) , 383-389
- https://doi.org/10.1007/s10545-006-0278-z
Abstract
‘Classical organic acidurias’ comprise isovaleric aciduria, propionic aciduria and methylmalonic aciduria. Available data from the literature suggest that the use of ‘new’ therapeutic strategies has improved survival but has not modified neurodevelopment. Progressive neurocognitive deterioration is almost invariably present in propionic and methylmalonic acidurias, while large-scale studies on the long-term outcome of patients with isovaleric aciduria are still lacking. In order to answer to some of the questions suggested by Wilson and Jungner in 1968 about the criteria of disease screening, we compared the natural history of patients with ‘classical’ organic acidurias diagnosed on clinical bases to those diagnosed through neonatal mass screening using tandem mass spectrometry. Decreased early mortality, less severe symptoms at diagnosis, and more favourable short-term neurodevelopmental outcome were recorded in patients identified through expanded newborn screening. The short duration of follow-up so far does not allow us to draw final conclusions about the effects of newborn screening on long-term outcome. The evaluation of the effect of neonatal screening on the detection rate of these three diseases showed that the incidence of isovaleric aciduria was significantly higher in the screening population than in clinically detected cases, with no changes for propionic and methylmalonic acidurias. Further multicentre longitudinal studies are needed to assess the usefulness of expanded newborn screening for ‘classical’ organic acidurias and to better understand the clinical spectrum of these diseases. This paper describes the long-term outcome and the impact of expanded newborn screening on the so-called ‘classical’ organic acidurias (propionic aciduria, methylmalonic aciduria and isovaleric aciduria).Keywords
This publication has 38 references indexed in Scilit:
- Methylmalonic and propionic acidaemias: Management and outcomeJournal of Inherited Metabolic Disease, 2005
- N‐Carbamylglutamate protects patients with decompensated propionicaciduria from hyperammonaemiaJournal of Inherited Metabolic Disease, 2005
- Clinical onset and prognosis of Asian children with organic acidemias, as detected by analysis of urinary organic acids using GC/MS, instead of mass screeningBrain & Development, 2005
- Propionic Acidemia Revisited: A Workshop ReportClinical Pediatrics, 2004
- Management of methylmalonic acidaemia by combined liver–kidney transplantationJournal of Inherited Metabolic Disease, 2004
- Clinical outcome and long-term management of 17 patients with propionic acidaemiaEuropean Journal of Pediatrics, 1996
- Neonatal-onset propionic acidemia: Neurologic and developmental profiles, and implications for managementThe Journal of Pediatrics, 1995
- Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemiaThe Journal of Pediatrics, 1994
- Cardiomyopathy in propionic acidaemiaEuropean Journal of Pediatrics, 1993
- Neurologic outcome of propionic acidemiaPediatric Neurology, 1992